** Shares of health insurer Cigna CI.N rise 1.7% to $340.70 premarket
** Co raises full-year earnings forecast and beats estimates for quarterly profit on strong performance in its pharmacy benefit management business and lower-than-expected medical costs in its insurance arm
** Co forecasts 2025 adj. profit of at least $29.60 per share vs previous estimate of $29.50 and analysts' estimate of $29.61, as per data compiled by LSEG
** Co reports Q1 adj. income from operations of $6.74, above estimates of $6.35
** Co's Q1 medical care ratio - the percentage of premiums spent on medical care, came in at 82.2%, lower than analysts' estimates of 82.63%
** "At first glance, Cigna rebounded from a challenging Q4 to post a strong Q1 beat. Although the guidance raise was modest relative to the beat, this could reflect some early-year conservatism"- brokerage Oppenheimer
** Up to last close, stock was up 21.4% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.